PCSK9 Inhibitor Use in the Real World: Data From the National Patient‐Centered Research Network
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
PCSK9 Inhibitor Use in the Real World: Data From the National Patient‐Centered Research Network
Authors
Keywords
-
Journal
Journal of the American Heart Association
Volume 8, Issue 9, Pages -
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2019-04-25
DOI
10.1161/jaha.118.011246
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy and Safety of Alirocumab in High-Risk Patients With Clinical Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial Hypercholesterolemia (from 5 Placebo-Controlled ODYSSEY Trials)
- (2018) Peter A. McCullough et al. AMERICAN JOURNAL OF CARDIOLOGY
- CARDIOVASCULAR RISK IN PATIENTS DENIED ACCESS TO PCSK9I THERAPY
- (2018) Seth J. Baum et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ‘Highest risk–highest benefit’ strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies
- (2017) Lieven Annemans et al. EUROPEAN HEART JOURNAL
- 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia
- (2017) Ulf Landmesser et al. EUROPEAN HEART JOURNAL
- Barriers to PCSK9 inhibitor prescriptions for patients with high cardiovascular risk: Results of a healthcare provider survey conducted by the National Lipid Association
- (2017) Jerome D. Cohen et al. Journal of Clinical Lipidology
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
- (2017) Waqas T. Qureshi et al. Journal of the American Heart Association
- Systematic Review and Network Meta‐Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia
- (2017) Peter P. Toth et al. Journal of the American Heart Association
- Nationwide Coverage and Cost-Sharing for PCSK9 Inhibitors Among Medicare Part D Plans
- (2017) Dhruv S. Kazi et al. JAMA Cardiology
- Long-term Low-Density Lipoprotein Cholesterol–Lowering Efficacy, Persistence, and Safety of Evolocumab in Treatment of Hypercholesterolemia
- (2017) Michael J. Koren et al. JAMA Cardiology
- Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin
- (2017) Robert P. Giugliano et al. JAMA Cardiology
- Efficacy of alirocumab according to background statin type and dose: pooled analysis of 8 ODYSSEY Phase 3 clinical trials
- (2017) Alberico L. Catapano et al. Scientific Reports
- Decade-Long Trends (2001 to 2011) in the Use of Evidence-Based Medical Therapies at the Time of Hospital Discharge for Patients Surviving Acute Myocardial Infarction
- (2016) Raghavendra Charan P. Makam et al. AMERICAN JOURNAL OF CARDIOLOGY
- Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease
- (2016) Dhruv S. Kazi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia
- (2015) Eliano Pio Navarese et al. ANNALS OF INTERNAL MEDICINE
- Burden of First and Recurrent Cardiovascular Events Among Patients With Hyperlipidemia
- (2015) Rajeshwari S. Punekar et al. CLINICAL CARDIOLOGY
- Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease
- (2015) Vera Bittner et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
- (2015) Christopher P. Cannon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Risk and Statin Use in the United States
- (2014) M. E. Johansen et al. ANNALS OF FAMILY MEDICINE
- Validation of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations
- (2014) Paul Muntner et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
- (2013) Neil J. Stone et al. CIRCULATION
- Overtreatment and Undertreatment of Hyperlipidemia in the Outpatient Setting
- (2012) Ashish Verma et al. SOUTHERN MEDICAL JOURNAL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now